Ultrasound predicts skeletal muscle fat infiltration in healthy middle‐aged and young adults: Validation against MRI
Experimental Physiology · 2026-04 · 111 (4) · 2135-2147
DOI: 10.1113/ep092865 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Experimental Physiology, online erschienen am 04.03.2026. Verfasst von R K Holsgrove-West und 7 weiteren Autor:innen. Beteiligte Einrichtung: Public Health and Sport Sciences, Medical School, University of Exeter, Exeter, UK. Hauptthemen laut MEDLINE: Muscle, Skeletal, Adipose Tissue. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EPSRC Healthcare Technologies, Welcome Trust Translational Research.
Abstract (Originalsprache)
This study developed an ultrasound prediction equation for measuring fat fraction in lower limb muscles of healthy middle‐aged and young participants and applied it in a randomised controlled trial (RCT) to assess the relationship between fat fraction and strength in exercising and non‐exercising females. Twenty‐eight participants were recruited into 50 years (8m, 5f, age 60.4 ± 5.7 years, BMI 24.8 ± 3.6 kg m −2 ) groups. T1‐weighted magnetic resonance imaging (MRI)‐Dixon fat fraction in gastrocnemius medialis (GM) and vastus lateralis (VL) and 1 H‐magnetic resonance spectroscopy for intramyocellular (IMCL) and extramyocellular (EMCL) lipid content in GM was used to validate ultrasound measures of muscle, subcutaneous fat thickness (SFT) and echointensity to generate a multivariable model of fat infiltration. For the RCT, 72 females aged 40–60 years were recruited to either a low impact resistance exercise (4–5 sessions/week for 12 weeks) or a control group, and muscle strength was tested using isokinetic dynamometry. Multiple linear regression models for ultrasound measurement of fat fraction were validated for GM ( r 2 = 0.71) and VL ( r 2 = 0.91). SFT was the dominant variable in the older group in GM (77%) and VL (92%), but of near equal proportion, with echointensity, in GM (52%) and VL (51%) in the younger group. Strength was negatively correlated with fat fraction ( r = −0.44). Strength increased in the exercising group, but fat fraction remained unchanged. A multivariable model using ultrasound measurements of SFT, muscle thickness, echointensity and age demonstrates that ultrasound is capable of predicting lower limb muscle fat infiltration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Public Health and Sport Sciences, Medical School, University of Exeter, Exeter, UK.
- Department of Mathematics and Statistics, Faculty of Environment, Science and Economy, University of Exeter, Exeter, UK.
- Medical Imaging Department, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
ORCID-Profile: R K Holsgrove-West, P M Słowiński, B T Wall, F B Stephens
Förderung
- EPSRC Healthcare Technologies
- Welcome Trust Translational Research
Zitieren
APA
Holsgrove-West, R. K., Słowiński, P. M., Svensen, E., Koscien, C., Fulford, J., Revuelta Iniesta, R., Wall, B. T., & Stephens, F. B. (2026). Ultrasound predicts skeletal muscle fat infiltration in healthy middle‐aged and young adults: Validation against MRI. Experimental Physiology, 111(4), 2135-2147. https://doi.org/10.1113/ep092865
Vancouver
Holsgrove-West RK, Słowiński PM, Svensen E, Koscien C, Fulford J, Revuelta Iniesta R, et al. Ultrasound predicts skeletal muscle fat infiltration in healthy middle‐aged and young adults: Validation against MRI. Experimental Physiology. 2026;111(4):2135-2147. doi:10.1113/ep092865
BibTeX
@article{HolsgroveWest2026,
author = {Holsgrove-West, R K and Słowiński, P M and Svensen, E and Koscien, C and Fulford, J and Revuelta Iniesta, R and Wall, B T and Stephens, F B},
title = {Ultrasound predicts skeletal muscle fat infiltration in healthy middle‐aged and young adults: Validation against MRI},
journal = {Experimental Physiology},
year = {2026},
volume = {111},
number = {4},
pages = {2135--2147},
doi = {10.1113/ep092865}
}
EUVIMED